facebook pixel

Chronicle Clinical Study

by | Apr 15, 2022

Have you been looking for a different approach to your chronic Cluster Headache?

A clinical research study is now enrolling eligible adults aged 18 to 75 years old.

The purpose of this clinical research study is to evaluate the long-term effects of a study medicine as a potential new treatment for those who suffer from chronic Cluster Headache (cCH).
You may be eligible to participate if you:

  • Are between the ages of 18 and 75 years old
  • Have a medical history of onset of cluster headache at or before age 50
  • Have a history of cCH in the last 12 months

If you are interested in joining the study, additional eligibility criteria will be assessed by the study doctor or staff. The commitment for this study is 14 months (60 weeks).

If you are qualified for the study you will not be paid for your participation, but will receive all study-related drugs, visits and tests at no cost.

To learn more about this clinical research study and see if it’s right for you, please contact the site nearest you at:

Michigan Headache and Neurological Institute
Dr. Joel Saper – Principal Investigator
Attn: Research Division 734-677-6000 option 4
3120 Professional Dr. Ann Arbor, MI 48104 research@mhni.com

New England Institute for Clinical Research
Dr. Peter McAllister – Principal Investigator
30 Buxton Farm Road #230 Stamford, CT 06905 info@neinh.com
Phone: 203-914-1903 x 130

Thomas Jefferson University – Jefferson Headache Center
Stephen Silberstein – Principal Investigator
Attn: Mary Hopkins mary.hopkins@jefferson.edu
900 Walnut St Philadelphia, Pa 19107

Dent Neurologic Institute
Dr. Laszlo Mechtler – Principal Investigator
Attn: Rebecca Hogan – Certified Clinical Research Coordinator 3980 Sheridan Drive – 6th Floor
Amherst, New York 14226
Phone: 716.558.5670


Skip to content